Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

XSpray

XSpray
2003 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
XSPRAY STOCK SYMBOL
$6.93 SHARE PRICE (As of Thursday Closing)
Description

XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors. The company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatment.

Formerly Known As
CENS Delivery
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
STO
Primary Office
  • Gunnar Asplunds Allé 32
  • 171 63 Solna
  • Sweden

+46 08-730 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore XSpray’s full profile, request a free trial.

XSpray Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$6.43 - $9.74 $105M $7.00 -$0.26 11.8K 15.1M

XSpray Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 93,592 100,325 90,063
Revenue 30 32 39 92
EBITDA (3,366) (2,205) (1,489) (396)
Net Income (3,743) (2,655) (1,617) (478)
Total Assets 32,606 34,764 19,717 5,694
Total Debt 569
Public Fundamental Data provided by Morningstar, Inc. disclaimer

XSpray Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore XSpray‘s full profile, request access.

Request full access to PitchBook

XSpray Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore XSpray‘s full profile, request access.

Request full access to PitchBook

XSpray Executive Team (4)

Name Title Board
Seat
Contact
Info
Per Andersson Ph.D Chief Executive Officer
Mustafa Demirbüker Ph.D Science Director & Co-Founder
Gérald Jesson Vice President, Operations

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

XSpray Board Members (9)

Name Representing Role Since Contact
Info
Carl-Johan Spak Ph.D Recipharm Board Member 000 0000
Hakan Nykvist XSpray Co-Founder & Board Member 000 0000
Hans Arwidsson Ph.D Self Board Member 000 0000
Jan Erik Nyström Self Board Member 000 0000
Maris Hartmanis Ph.D XSpray Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 9 board members. Get the full list »